T0	Participants 32 71	patients after a myocardial infarction:
T1	Participants 90 108	post-hospital data
T2	Participants 171 197	myocardial infarction (MI)
T3	Participants 244 306	patients admitted for the first MI with recurrent MI patients.
T4	Participants 537 644	An inception cohort of patients enrolled in the Beta-Blocker in Heart Attack Trial (n = 2830) was included.
T5	Participants 678 713	in-hospital and post-hospital data)